Zhimin Lu

20.6k total citations · 11 hit papers
207 papers, 14.7k citations indexed

About

Zhimin Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhimin Lu has authored 207 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Molecular Biology, 83 papers in Cancer Research and 33 papers in Oncology. Recurrent topics in Zhimin Lu's work include Cancer, Hypoxia, and Metabolism (59 papers), RNA modifications and cancer (23 papers) and Metabolism, Diabetes, and Cancer (22 papers). Zhimin Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (59 papers), RNA modifications and cancer (23 papers) and Metabolism, Diabetes, and Cancer (22 papers). Zhimin Lu collaborates with scholars based in China, United States and South Korea. Zhimin Lu's co-authors include Tony Hunter, Weiwei Yang, Yan Xia, Yanhua Zheng, Xinjian Li, David H. Hawke, Xu Qian, Ying Meng, Daqian Xu and Kenneth Aldape and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Zhimin Lu

194 papers receiving 14.6k citations

Hit Papers

Phosphorylation of β-Cate... 2003 2026 2010 2018 2007 2012 2012 2020 2003 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zhimin Lu 10.6k 5.8k 2.5k 1.6k 1.4k 207 14.7k
Li Ma 13.5k 1.3× 7.6k 1.3× 3.0k 1.2× 1.6k 1.0× 1.1k 0.8× 260 18.4k
Costas A. Lyssiotis 8.2k 0.8× 4.8k 0.8× 3.7k 1.5× 1.9k 1.2× 698 0.5× 144 13.3k
Wen Xue 10.7k 1.0× 3.8k 0.7× 2.5k 1.0× 1.4k 0.9× 1.3k 0.9× 204 13.9k
Paola Chiarugi 9.4k 0.9× 4.7k 0.8× 4.1k 1.6× 3.0k 1.9× 1.8k 1.2× 186 15.5k
Christian M. Metallo 8.2k 0.8× 4.8k 0.8× 1.3k 0.5× 1.1k 0.7× 945 0.7× 125 12.3k
Heiko Hermeking 12.1k 1.1× 6.2k 1.1× 4.3k 1.7× 1.2k 0.7× 1.2k 0.8× 138 15.3k
Marian H. Harris 6.8k 0.6× 4.2k 0.7× 1.6k 0.6× 1.9k 1.2× 775 0.5× 78 11.1k
Nicholas Denko 6.5k 0.6× 5.0k 0.9× 1.5k 0.6× 805 0.5× 1.4k 1.0× 93 10.2k
Naohiko Seki 12.1k 1.1× 8.2k 1.4× 2.1k 0.8× 1.1k 0.7× 871 0.6× 357 16.4k
Huafeng Zhang 7.4k 0.7× 5.3k 0.9× 1.5k 0.6× 1.3k 0.8× 478 0.3× 133 11.4k

Countries citing papers authored by Zhimin Lu

Since Specialization
Citations

This map shows the geographic impact of Zhimin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhimin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhimin Lu more than expected).

Fields of papers citing papers by Zhimin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhimin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhimin Lu. The network helps show where Zhimin Lu may publish in the future.

Co-authorship network of co-authors of Zhimin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhimin Lu. A scholar is included among the top collaborators of Zhimin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhimin Lu. Zhimin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Heng, Xiaoying Chen, Qingxia Ma, et al.. (2025). Discovery and structural basis of endogenous and exogenous inhibitors of the proton-activated-chloride channel. Cell Reports. 44(7). 115998–115998. 1 indexed citations
2.
Wang, Lin-Jian, Wenjing Zhang, Xiaojun Zhu, et al.. (2025). Placental targeted drug delivery: a review of recent progress. Nanoscale. 17(14). 8316–8335. 2 indexed citations
3.
Zhao, Gaoxiang, Shudi Luo, Qingxia Ma, et al.. (2025). Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. Nature Communications. 16(1). 7156–7156.
4.
Yao, Pengbo, Gaoxiang Zhao, Min Li, Wensheng Qiu, & Zhimin Lu. (2024). Abrogation of nuclear entry of TERT by fructose 1,6‐bisphosphatase 1‐mediated dephosphorylation. Cancer Communications. 44(10). 1102–1105. 3 indexed citations
5.
Ding, Ling, et al.. (2024). Obesity-derived macrophages upregulate TNF-α to induce apoptosis in glial cell via the NF-κB/PHLPP1 axis. International Immunopharmacology. 141. 112962–112962. 4 indexed citations
6.
Liu, Guijun, Xuxiao He, Gaoxiang Zhao, & Zhimin Lu. (2024). Complement regulation in tumor immune evasion. Seminars in Immunology. 76. 101912–101912. 8 indexed citations
8.
He, Haiyan, Liwei Xiao, Juhong Wang, Dong Guo, & Zhimin Lu. (2023). Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2. Cancer Communications. 43(3). 387–390. 22 indexed citations
9.
Li, Shan, Ying Shirley Meng, Cheng Chen, et al.. (2023). Cytosolic DNA sensing by cGAS/STING promotes TRPV2-mediated Ca2+ release to protect stressed replication forks. Molecular Cell. 83(4). 556–573.e7. 30 indexed citations
10.
Zhao, Gaoxiang, Qingxia Ma, Yang Huang, et al.. (2023). Base editing of the mutated TERT promoter inhibits liver tumor growth. Hepatology. 79(6). 1310–1323. 8 indexed citations
11.
Yin, Jianxing, Xiefeng Wang, Xin Ge, et al.. (2023). Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas. Nature Communications. 14(1). 5913–5913. 24 indexed citations
12.
Wang, Juhong, Fei Shao, Yannan Yang, et al.. (2022). A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability. Cancer Communications. 42(10). 1008–1027. 45 indexed citations
13.
Ma, Qingxia, Qianqian Xu, Jiaojiao Zhao, et al.. (2021). Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance. Cancer Letters. 520. 243–254. 21 indexed citations
14.
Tang, Wei, Xin Qi, Rilei Yu, et al.. (2021). PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells. Cancer Biology and Medicine. 19(4). 486–503. 12 indexed citations
15.
Jiang, Hongfei, Lei Zhu, Daqian Xu, & Zhimin Lu. (2020). A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis. Cancer Communications. 40(9). 389–394. 30 indexed citations
17.
Qian, Xu, Xinjian Li, Lin Tan, et al.. (2017). Conversion of PRPS Hexamer to Monomer by AMPK-Mediated Phosphorylation Inhibits Nucleotide Synthesis in Response to Energy Stress. Cancer Discovery. 8(1). 94–107. 67 indexed citations
18.
Yang, Weiwei, Yan Xia, Yu Cao, et al.. (2012). EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis. Molecular Cell. 48(5). 771–784. 219 indexed citations
19.
Chiu, Wen‐Tai, Hsueh‐Te Lee, Kenneth Aldape, et al.. (2011). Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition. Cancer Research. 71(14). 4932–4943. 55 indexed citations
20.
Liu, Shuying, Xianjun Fang, Hassan Hall, et al.. (2008). Homozygous deletion of glycogen synthase kinase 3β bypasses senescence allowing Ras transformation of primary murine fibroblasts. Proceedings of the National Academy of Sciences. 105(13). 5248–5253. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026